Annual Total Expenses
$127.59 M
-$29.54 M-18.80%
31 December 2023
Summary:
Adverum Biotechnologies annual total expenses is currently $127.59 million, with the most recent change of -$29.54 million (-18.80%) on 31 December 2023. During the last 3 years, it has risen by +$9.64 million (+8.17%). ADVM annual total expenses is now -18.80% below its all-time high of $157.13 million, reached on 31 December 2022.ADVM Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$30.22 M
+$9.34 M+44.72%
30 September 2024
Summary:
Adverum Biotechnologies quarterly total expenses is currently $30.22 million, with the most recent change of +$9.34 million (+44.72%) on 30 September 2024. Over the past year, it has dropped by -$4.31 million (-12.48%). ADVM quarterly total expenses is now -32.15% below its all-time high of $44.54 million, reached on 30 June 2021.ADVM Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADVM Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.8% | -12.5% |
| 3 y3 years | +8.2% | -21.6% |
| 5 y5 years | +70.8% | +74.4% |
ADVM Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -18.8% | +8.2% | -31.4% | +44.7% |
| 5 y | 5 years | -18.8% | +85.5% | -32.1% | +74.4% |
| alltime | all time | -18.8% | +6925.9% | -32.1% | >+9999.0% |
Adverum Biotechnologies Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $30.22 M(+44.7%) |
| June 2024 | - | $20.88 M(-22.2%) |
| Mar 2024 | - | $26.84 M(+2.6%) |
| Dec 2023 | $127.59 M(-18.8%) | $26.16 M(-24.2%) |
| Sept 2023 | - | $34.53 M(+4.4%) |
| June 2023 | - | $33.06 M(-2.3%) |
| Mar 2023 | - | $33.84 M(-0.3%) |
| Dec 2022 | $157.13 M(+2.3%) | $33.94 M(-17.3%) |
| Sept 2022 | - | $41.04 M(-6.8%) |
| June 2022 | - | $44.02 M(+15.5%) |
| Mar 2022 | - | $38.13 M(+10.8%) |
| Dec 2021 | $153.62 M(+30.2%) | $34.42 M(-10.7%) |
| Sept 2021 | - | $38.52 M(-13.5%) |
| June 2021 | - | $44.54 M(+23.2%) |
| Mar 2021 | - | $36.14 M(-0.7%) |
| Dec 2020 | $117.95 M(+71.5%) | $36.38 M(+29.9%) |
| Sept 2020 | - | $28.00 M(-5.9%) |
| June 2020 | - | $29.77 M(+25.2%) |
| Mar 2020 | - | $23.79 M(+21.1%) |
| Dec 2019 | $68.80 M(-7.9%) | $19.65 M(+13.4%) |
| Sept 2019 | - | $17.33 M(+7.6%) |
| June 2019 | - | $16.10 M(+2.5%) |
| Mar 2019 | - | $15.71 M(-6.7%) |
| Dec 2018 | $74.69 M | $16.83 M(-12.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $19.31 M(-5.3%) |
| June 2018 | - | $20.40 M(+12.3%) |
| Mar 2018 | - | $18.16 M(+13.1%) |
| Dec 2017 | $60.70 M(+8.3%) | $16.06 M(+6.8%) |
| Sept 2017 | - | $15.03 M(+19.7%) |
| June 2017 | - | $12.56 M(-26.4%) |
| Mar 2017 | - | $17.05 M(+34.5%) |
| Dec 2016 | $56.02 M(+17.8%) | $12.68 M(-12.6%) |
| Sept 2016 | - | $14.51 M(+11.0%) |
| June 2016 | - | $13.07 M(-17.1%) |
| Mar 2016 | - | $15.77 M(+25.5%) |
| Dec 2015 | $47.57 M(+90.5%) | $12.57 M(-17.1%) |
| Sept 2015 | - | $15.15 M(+50.3%) |
| June 2015 | - | $10.09 M(+3.3%) |
| Mar 2015 | - | $9.76 M(-7.9%) |
| Dec 2014 | $24.97 M(+623.0%) | $10.61 M(+30.2%) |
| Sept 2014 | - | $8.14 M(+77.5%) |
| June 2014 | - | $4.59 M(+180.4%) |
| Mar 2014 | - | $1.64 M(-15.2%) |
| Dec 2013 | $3.45 M(+90.2%) | $1.93 M(+147.9%) |
| Sept 2013 | - | $778.00 K(+10.4%) |
| June 2013 | - | $705.00 K(+1578.6%) |
| Mar 2013 | - | $42.00 K |
| Dec 2012 | $1.82 M | - |
FAQ
- What is Adverum Biotechnologies annual total expenses?
- What is the all time high annual total expenses for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual total expenses year-on-year change?
- What is Adverum Biotechnologies quarterly total expenses?
- What is the all time high quarterly total expenses for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly total expenses year-on-year change?
What is Adverum Biotechnologies annual total expenses?
The current annual total expenses of ADVM is $127.59 M
What is the all time high annual total expenses for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual total expenses is $157.13 M
What is Adverum Biotechnologies annual total expenses year-on-year change?
Over the past year, ADVM annual total expenses has changed by -$29.54 M (-18.80%)
What is Adverum Biotechnologies quarterly total expenses?
The current quarterly total expenses of ADVM is $30.22 M
What is the all time high quarterly total expenses for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly total expenses is $44.54 M
What is Adverum Biotechnologies quarterly total expenses year-on-year change?
Over the past year, ADVM quarterly total expenses has changed by -$4.31 M (-12.48%)